Redpin Therapeutics, Inc. — Form D
Redpin Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-29. The offering totals $5.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-03-29
- Form: D
- Accession: 0001735933-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.5M
- Remaining: $3.5M
- Investors: 1
- Date of first sale: 2018-03-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-308885
Issuer
- Name: Redpin Therapeutics, Inc.
- CIK: 0001735933
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1392 MADISON AVENUE, NEW YORK, NY, 10029
- Phone: 9179719655
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Elma Hawkins | Director | Brooklyn, NY |
| Elma Hawkins | Executive Officer | Brooklyn, NY |
Other filings by this issuer (1)
More